VolitionRx VNRX Stock
VolitionRx Price Chart
VolitionRx VNRX Financial and Trading Overview
| VolitionRx stock price | 2 USD |
| Previous Close | 2.67 USD |
| Open | 2.68 USD |
| Bid | 2.51 USD x 50000 |
| Ask | 2.73 USD x 30000 |
| Day's Range | 2.57 - 2.9 USD |
| 52 Week Range | 1.91 - 18.8 USD |
| Volume | 227.59K USD |
| Avg. Volume | 627.31K USD |
| Market Cap | 22.08M USD |
| Beta (5Y Monthly) | 1.031 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.25 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 20.21 USD |
VNRX Valuation Measures
| Enterprise Value | 24.85M USD |
| Trailing P/E | N/A |
| Forward P/E | 0.24537037 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 12.779565 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 14.386 |
| Enterprise Value/EBITDA | -1.197 |
Trading Information
VolitionRx Stock Price History
| Beta (5Y Monthly) | 1.031 |
| 52-Week Change | -75.46% |
| S&P500 52-Week Change | 27.29% |
| 52 Week High | 18.8 USD |
| 52 Week Low | 1.91 USD |
| 50-Day Moving Average | 3.02 USD |
| 200-Day Moving Average | 6.62 USD |
VNRX Share Statistics
| Avg. Volume (3 month) | 627.31K USD |
| Avg. Daily Volume (10-Days) | 287.77K USD |
| Shares Outstanding | 8.33M |
| Float | 6.88M |
| Short Ratio | 1.27 |
| % Held by Insiders | 13.18% |
| % Held by Institutions | 16.85% |
| Shares Short | 269.07K |
| Short % of Float | 3.52% |
| Short % of Shares Outstanding | 3.32% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1077.85% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -166.69% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 1.73M USD |
| Revenue Per Share (ttm) | 0.32 USD |
| Quarterly Revenue Growth (yoy) | 133.20% |
| Gross Profit (ttm) | 1.73M USD |
| EBITDA | -20754864 USD |
| Net Income Avi to Common (ttm) | -23357028 USD |
| Diluted EPS (ttm) | -4.25 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.12M USD |
| Total Cash Per Share (mrq) | 0.14 USD |
| Total Debt (mrq) | 11.46M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.169 |
| Book Value Per Share (mrq) | -0.272 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -19683334 USD |
| Levered Free Cash Flow (ttm) | -8515099 USD |
Profile of VolitionRx
| Country | United States |
| State | NV |
| City | Henderson |
| Address | 1489 West Warm Springs Road |
| ZIP | 89014 |
| Phone | 512 774 8930 |
| Website | https://volition.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 75 |
VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes. It also provides Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is headquartered in Henderson, Nevada.
Q&A For VolitionRx Stock
What is a current VNRX stock price?
VolitionRx VNRX stock price today per share is 2 USD.
How to purchase VolitionRx stock?
You can buy VNRX shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for VolitionRx?
The stock symbol or ticker of VolitionRx is VNRX.
Which industry does the VolitionRx company belong to?
The VolitionRx industry is Medical Devices.
How many shares does VolitionRx have in circulation?
The max supply of VolitionRx shares is 8.63M.
What is VolitionRx Price to Earnings Ratio (PE Ratio)?
VolitionRx PE Ratio is now.
What was VolitionRx earnings per share over the trailing 12 months (TTM)?
VolitionRx EPS is -4.25 USD over the trailing 12 months.
Which sector does the VolitionRx company belong to?
The VolitionRx sector is Healthcare.
VolitionRx VNRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NYSE American Composite Index XAX | 8754.68 USD — |
+0.05
|
— — | 8671.29 USD — | 8765.02 USD — | — - | — — |
- {{ link.label }} {{link}}